GAMMAGARD LIQUID is a ready-to-use liquid medicine that is given in a vein (intravenously) or under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
From information about primary immunodeficiency (PI) to what to expect with infusing, find helpful resources here.
Whether you’ve just been diagnosed with PI, have been prescribed GAMMAGARD LIQUID, or just want to learn more, this brochure can help.
You can go over some questions to help prepare for your doctor’s appointment.
If you’re doing subQ infusions at home, it’s important to track the details of your infusions like your dose, any reactions, etc. Plus, this is a great way to jot down any notes or questions about your infusion for your healthcare team.
Ask your doctor or Specialty Pharmacy.
Curious about how GAMMAGARD LIQUID is made? Find out here. It’s a short but pretty interesting video.
*Every 3 or 4 weeks.
These foundations and professional societies each focus on a multitude of different things regarding primary immunodeficiency (PI). They’re worth looking into if you have a minute or two.
My Life, My Story events are led by nurses and patient ambassadors living with primary immunodeficiency (PI). Learn more at MyLifeMyStory.comopens in a new tab.
IDF* is a national patient organization dedicated to improving the diagnosis, treatment, and quality of life of people living with PI through advocacy, education, and research. Learn more at primaryimmune.orgopens in a new tab.
JMF* is dedicated to early and precise diagnosis, meaningful treatments, and, ultimately, cures of the known PI diseases through research, physician education, patient support, advocacy, public awareness, and newborn screening. Learn more at info4pi.orgopens in a new tab.
AAAAI,* a professional society for clinical immunologists, is a dedicated resource for information about PI. Search for PI under the list of conditions to find links to facts about PI, as well as support organizations and helpful guides. The site also has a tool to search for an allergist/immunologist near you. Learn more at aaaai.orgopens in a new tab.
*This organization is a third-party resource and not associated with Takeda.
*Every 3 or 4 weeks.
IMPORTANT SAFETY INFORMATION and serious warnings regarding blood clots, decreased kidney function or kidney failure
What is the most important information that I should know about GAMMAGARD LIQUID?
GAMMAGARD LIQUID can cause the following serious reactions: severe allergic reactions causing difficulty in breathing or skin rashes; decreased kidney function or kidney failure; blood clots in the heart, brain, lungs or elsewhere in the body; severe headache, drowsiness, fever, painful eye movements, or nausea and vomiting; dark colored urine, swelling, fatigue, or difficulty breathing.
INDICATION
What is GAMMAGARD LIQUID?
GAMMAGARD LIQUID is a ready-to-use liquid medicine that is given in a vein (intravenously) or under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
Important Safety Information
What is the most important information that I should know about GAMMAGARD LIQUID?
GAMMAGARD LIQUID can cause the following serious reactions:
Who should not use GAMMAGARD LIQUID?
Do not use GAMMAGARD LIQUID if you:
What should I avoid while taking GAMMAGARD LIQUID?
What are the possible or reasonably likely side effects of GAMMAGARD LIQUID?
GAMMAGARD LIQUID can cause serious side effects. If any of the following problems occur after starting GAMMAGARD LIQUID, stop the infusion immediately and contact your HCP or call emergency services:
The following one or more possible reactions may occur at the site of infusion of GAMMAGARD LIQUID for PI, generally go away within a few hours, and are less likely after the first few infusions:
During the infusion of GAMMAGARD LIQUID for PI, look out for the first signs of the following common side effects:
These are not all the possible side effects. Talk to your HCP about any side effect that bothers you or that does not go away.
For additional safety information including Warning about Blood Clots, Decreased Kidney Function, and Kidney Failure, click for Information for Patientsopens in a new tab and discuss with your HCP.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatchopens in a new tab, or call 1-800-FDA-1088.